Redburn Atlantic initiated coverage on BridgeBio Pharma with a new price target
$BBIO
Biotechnology: Pharmaceutical Preparations
Health Care
Redburn Atlantic initiated coverage of BridgeBio Pharma with a rating of Buy and set a new price target of $50.00